Market Newsdesk

CEDAR RAPIDS, Iowa, July 17, 2026 (GLOBE NEWSWIRE) — United Fire Group, Inc. (Nasdaq: UFCS) (UFG) announced today that its second quarter 2026 earnings results will be released after the market closes on Monday, August 3, 2026. An earnings call will be held on Tuesday, August 4, 2026 at 9 a.m. CT to allow securities analysts, shareholders and other interested parties the opportunity to hear management discuss the company’s second quarter 2026 results.

Teleconference: Dial-in information for the call is toll-free 1-844-492-3723 (international 1-412-542-4184). Participants should request to join the United Fire Group call. The event will be archived and available for digital replay through August 11, 2026. The replay access information is toll-free 1-855-669-9658 (international 1-412-317-0088); access code no. 2119197.

Webcast: A webcast of the teleconference can be accessed at https://ir.ufginsurance.com/events-and-presentations/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=sEg6VEdp. The archived audio webcast will be available for one year.

Transcript: A transcript of the teleconference will be available on the company’s website soon after the completion of the teleconference.

About UFG:

Founded in 1946 as United Fire & Casualty Company, UFG, through its insurance company subsidiaries, is engaged in the business of writing property and casualty insurance. The company is licensed as a property and casualty insurer in 50 states and the District of Columbia, and is represented by approximately 850 independent agencies. A.M. Best Company assigns a rating of “A-” (Excellent) for members of the United Fire & Casualty Group. For more information about UFG, visit www.ufginsurance.com.

Contact:

Investor relations

Email: [email protected]

Media inquiries

Email: [email protected]

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) securities between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”).

The Complaint alleges that Defendants made materially false and misleading statements regarding the true state of Regeneron’s Phase III Fianlimab-Libtayo Study; notably, that its preliminary statistical assumptions were fundamentally flawed, that the active treatment arm was failing to achieve meaningful clinical differentiation over standard therapies, and that the trial would ultimately fail to reach statistical significance on its primary endpoint even without overperformance of the control arm. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Regeneron’s securities at artificially inflated prices.

The Complaint alleges that the full truth finally emerged after-market on May 15, 2026, when Regeneron issued a press release announcing that the “Phase 3 Trial of Fianlimab . . . did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS).”

The Complaint also alleges that the investors and analysts again reacted promptly to Regeneron’s revelation. The Complaint continues to allege that the price of Regeneron’s common stock declined even further from a closing market price of $698.25 per share on May 15, 2026, Regeneron’s stock price fell to $629.68 per share on May 18, 2026, a decline of about 9.8% in the span of one day.

Investors who purchased or otherwise acquired shares of Regeneron should contact the Firm prior to the September 14, 2026 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.

SEATTLE, July 17, 2026 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that updated data on the Company’s [²¹²Pb]VMT-α-NET program have been accepted for presentation as detailed below at the European Society of Medical Oncology (ESMO) Congress 2026 taking place October 23 to 27, 2026 in Madrid, Spain. ESMO plans to release further details for regular abstracts on October 19, 2026.

About [²¹²Pb]VMT-α-NET

Perspective designed [²¹²Pb]VMT-α-NET to target somatostatin receptor subtype 2 (SSTR2), and to deliver the alpha-emitting radioisotope lead-212, or ²¹²Pb, to tumor sites expressing SSTR2. The Company is conducting a multi-center, open-label, dose-escalation and dose-expansion study (clinicaltrials.gov identifier NCT05636618) of [²¹²Pb]VMT-α-NET in patients with unresectable or metastatic SSTR2-positive tumors who have not received prior radiopharmaceutical therapies (RPT).

Interim clinical data from the study, with a data cut-off date of April 17, 2026, were presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in May 2026. These data included efficacy results for half of the patients in Cohort 2 and both patients in Cohort 1. Initial efficacy data for the remaining patients in Cohort 2 and patients in Cohorts 3 and 4 are pending. The Company plans to submit additional data for presentation at future medical conferences in 2026 and 2027.

About Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc. is a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-generating isotope ²¹²Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. The Company is also developing complementary imaging techniques that incorporate the same targeting moieties, which provides the opportunity to personalize treatment and optimize patient outcomes. This “theranostic” approach enables visualization of the specific tumor and subsequent treatment, potentially improving efficacy and minimizing toxicity.

The Company is advancing a portfolio of clinical-stage programs in the U.S., including VMT-α-NET (neuroendocrine tumors), VMT01 (melanoma), and PSV359 (solid tumors).

The Company is expanding its regional finished drug product candidate supply network, enabled by its proprietary ²²⁴Ra/²¹²Pb generator platform used to manufacture clinical drug product candidates, to support the delivery of patient-ready drug product candidates for clinical trials and, if approved, commercial operations.

For more information, please visit the Company’s website at www.perspectivetherapeutics.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Statements in this press release that are not statements of historical fact are forward-looking statements. Words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “estimate,” “believe,” “predict,” “potential,” or “continue” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements contain these identifying words. Forward-looking statements in this press release include statements concerning, among other things, the Company’s preclinical and clinical development plans and the expected timing for the release of additional data from its clinical programs; the Company’s beliefs that its product candidates address certain unmet medical needs; the Company’s expectations regarding regulatory pathways for its product candidates; the Company’s expectations regarding its interactions with regulatory agencies and the expected timing thereof; the Company’s regional distribution and manufacturing capabilities; and other statements that are not historical fact.

The Company may not actually achieve the plans, intentions, or expectations disclosed in the forward-looking statements, and you should not place undue reliance on the forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the Company’s actual results to differ materially from the results described in or implied by the forward-looking statements. Known risk factors include that the Company’s clinical trials may be more costly or take longer to complete than anticipated, or may never be completed, or may not generate results that warrant future development of the tested product candidate; the Company may elect to change its strategy regarding its product candidates and clinical development activities; economic and market conditions may worsen; and risks related to the sufficiency of the Company’s cash resources for its future operating expenses and capital expenditures. A more complete discussion of the risks and uncertainties facing the Company appears under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), in the Company’s other filings with the SEC, and in the Company’s future reports to be filed with the SEC and available at www.sec.gov. Forward-looking statements contained in this news release are made as of this date. Unless required to do so by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Media and Investor Relations Contacts:

Perspective Therapeutics IR:

Annie J. Cheng, CFA
[email protected]

ENTENTE Network of Companies

Katie Morris, PhD
[email protected]

LONDON, July 17, 2026 (GLOBE NEWSWIRE) — Roundtable (Nasdaq: RTB), the only AI-powered, DeFi-enabled enterprise media platform, today announced a comprehensive technology partnership with Mario Nawfal, whose content generates more than 1 billion monthly video views. Under the partnership, Roundtable will power Nawfal’s non-social digital platform, marionawfal.com, including publishing, monetization, syndication and business operations through its fully integrated technology stack.

Nawfal’s legendary portfolio of exclusive, long-form interviews with global business, technology and political leaders will be distributed through his own domain on Roundtable’s Web3 platform. His social media presence on X, including 24/7 global news coverage, will remain unchanged. MarioNawfal.com will serve as his owned-and-operated destination and secure IP vault.

“Roundtable’s platform is undoubtedly transformative for the professional media industry,” said Nawfal, who has emerged as a major force in global news. “Their technology provides advantages only DeFi, AI and on-chain publishing can offer. I believe this platform can help restore independence and influence to high-integrity journalism.”

“The world’s most innovative, passionate, modern journalist is the perfect partner to unveil the features of the world’s most powerful digital media platform, said Roundtable CEO, James Heckman. “In a crowded marketplace, Mario has risen to the top, maintaining his civility and objectivity – and so we’re thrilled to include him with our premium media partners.

“The confidence Roundtable’s team brings, with three decades of major media technology leadership experience, made the decision to platform MarioNawfal.com on Roundtable simple,” said Nawfal’s CEO, Wahid Chammis. “Frankly, no other platform provides the full technology stack, and Roundtable was the only company to invest early enough to fully leverage AI, DeFi and blockchain. As a result, the industry’s most sophisticated media operating system is positioned to help professional media finally control its own assets and destiny.”

About Roundtable (RTB Digital, Inc.)

Roundtable (NASDAQ: RTB) is the world’s only AI/DeFi-powered Enterprise Media Platform, integrating distribution, publishing, monetization, community, syndication and DeFi payment operations. The Web3 platform was developed over years by CTO Eyal Hertzog, inventor of DeFi technology, and co-founder James Heckman, creator of the first social network, blogging platform, premium ad marketplace (PMP), social-targeted ad platform, and led digital strategy for News Corp and Yahoo. For more information, visit rtb.io.

About Mario Nawfal and Citizen Journalism Network (CJN)

Founded by Mario Nawfal, CJN is a leading digital media network and corporate accelerator, which operates a dual-model ecosystem structured around high-impact media and a proprietary venture incubation. CJN is one of the largest decentralized digital broadcasting networks globally, specializing real-time, interactive breaking news, financial markets, and technology. The network generates significant global visibility, facilitating large-scale public engagement and audience capture.

Cautionary Note Regarding Forward-Looking Statements

This press release includes information that constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on the Company’s current beliefs, assumptions and expectations regarding future events, which in turn are based on information currently available to the Company. Such forward-looking statements include statements that are characterized by future or conditional words such as “may,” “will,” “expect,” “intend,” “anticipate,” “believe,” “estimate,” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such forward-looking statements include statements regarding the timing and effects of the merger transaction and the integration of the business of RTB into the combined post-merger company and the effects of the overall merger transaction and future operations of the post-merger company. By their nature, forward-looking statements address matters that are subject to risks and uncertainties. A variety of factors could cause actual events and results to differ materially from those expressed in or contemplated by the forward-looking statements, such as the post-merger company being able to maintain its listing on Nasdaq for the common stock, having sufficient capital for its operations and planned business expansion, and developing its business and capturing users for its services. Other risk factors affecting the Company are discussed in detail in the Company’s filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by applicable laws.

Public Relations Contact:

Mehab Qureshi, RTB Digital, Inc.
+91 90289 77198, [email protected]

SAN FRANCISCO, July 17, 2026 (GLOBE NEWSWIRE) — National shareholder rights firm Hagens Berman alerts investors in Roblox Corporation (NYSE: RBLX) that the alleged class period in the ongoing securities class action litigation has been expanded. A new lawsuit now covers investors who purchased or otherwise acquired Roblox common stock between October 31, 2024 through April 30, 2026, inclusive.

National shareholder rights firm Hagens Berman is investigating the legal claims that Roblox and its co-defendants violated the federal securities laws. The firm encourages Roblox investors who suffered substantial losses to submit your losses now.

Class Period: Oct. 31, 2024 – Apr. 30, 2026
Lead Plaintiff Deadline: Aug. 7, 2026
Visit:www.hbsslaw.com/investor-fraud/rblx
Contact the Firm Now: [email protected]
                                         844-916-0895
Roblox Corporation (RBLX) Securities Class Action:

The primary focus of the litigation is on the propriety of Roblox’s disclosures about its commitment toward protecting the safety of young users of its platform and the recent the impact on its business and prospects of the age-check verification rollout aimed at increasing safety within certain social features on its platform. The rollout began in November 2025.

During the Class Period, Roblox and its senior management have assured investors that “safety would be paramount[,]” “building safety into our products has been a huge effort[,]” and “[o]ur approach to safety includes multiple proactive measures as well as parental controls[.]” They have also emphasized that “b]ecause our Platform includes children aged 5 and over, our safety and civility policies are purpose-built to be strict.”

Investors slowly learned the truth through a series of disclosures beginning on October 30, 2025. That day, the Company revealed that it would be instituting enhanced age verification technology globally beginning in January 2026. On this news, the price of the Company’s common stock declined 16% from $133.74 per share to $113.00 per share, wiping out $13 billion in market value.

Then, on April 30, 2026, Roblox revealed a steep deceleration in year-over-year and sequential DAU growth, slashed its 2026 revenue guidance (reflecting ongoing shrinkage in DAU growth), and severely cut its 2026 bookings growth midpoint from 24% to just 10%, investors glimpsed what was really going on.

Roblox said just 51% of its global DAUs age checked and also said that “as a result of age check […] we have seen a reduction in app store ratings, and we believe this may be contributing to a reduction in organic sign-ups that typically flow from app stores.” Roblox also said its lowered prospects are the result of “continued friction” resulting from the age-check rollout.

“We’re focused on when Roblox and its management knew of the adverse consequences of the age-check rollout and whether they intentionally misled investors it,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Roblox and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now.

If you’d like more information and answers to other frequently asked questions about the Roblox case and the firm’s investigation, read more.

Whistleblowers: Persons with non-public information regarding Roblox should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Contact:

Reed Kathrein, 844-916-0895

SAN FRANCISCO, July 17, 2026 (GLOBE NEWSWIRE) — National shareholder rights firm Hagens Berman is investigating claims in a securities class action alleging violations of U.S. securities laws by Hub Group, Inc. (NASDAQ: HUBG). The suit contends the company and its senior executives provided false and misleading information to investors regarding the integrity of its financial reporting, revenue recognition practices, and the effectiveness of its internal controls.

REPORT YOUR HUBG LOSSES TO HBSS NOW

Class Period: Apr. 28, 2023 – May 11, 2026
Lead Plaintiff Deadline: Aug. 28, 2026
Visit:www.hbsslaw.com/investor-fraud/hubg
Contact the Firm Now:[email protected]
                                       844-916-0895

Hub Group, Inc. (HUBG) Securities Class Action:

The suit alleges that Hub Group’s repeated disclosures throughout 2026 have revealed a pattern of severe accounting irregularities. The complaint claims the company intentionally or recklessly misled investors during the Class Period (April 28, 2023 – May 11, 2026) by:

• Understating Costs: Failing to accurately report purchased transportation costs and accounts payable, leading to a $77 million accounting error in 2025 alone.
• Improper Revenue Recognition: Prematurely or incorrectly recognizing transactions, which rendered the company’s 2023 and 2024 annual reports materially misstated.
• Internal Control Deficiencies: Maintaining inadequate disclosure controls and internal control over financial reporting, despite repeated public assurances of their effectiveness.

The Truth Emerges

The complaint alleges that the market’s perception of Hub Group’s stability was dismantled by two major corrective disclosures:

1. February 2026: The company revealed that financial statements for the first three quarters of 2025 were unreliable, causing an immediate 18% decline in share price.
2. May 2026: Hub Group announced that its 2023 and 2024 annual reports were also materially misstated, compounding the decline with an additional 13% drop in share price.

These revelations wiped out over $890 million in market capitalization, prompting the departure of the company’s Chief Financial Officer and Chief Operating Officer in May 2026.

“Now that Hub Group has almost cleaned out its C-suite following accounting improprieties reaching all the way back to 2023, the core focus of our investigation is whether they were intentional or reckless with the goal of making financial metrics appear better than they actually were. We’re also looking to see whether additional problems will surface when the company’s review is completed,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

Investor Rights and Lead Plaintiff Deadline

Investors who purchased or acquired Hub Group common stock between April 28, 2023, and May 11, 2026, may be eligible to serve as lead plaintiff. The court-imposed deadline to move for appointment as lead plaintiff is August 28, 2026.

• 
  Submit your losses now
  
• Contact Our Attorneys:
  
  [email protected]
  
• HBSS Investor Hotline: 844-916-0895

If you’d like more information and answers to other frequently asked questions about the Hub Group case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Hub Group should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact:

Reed Kathrein, 844-916-0895

SAN FRANCISCO, July 17, 2026 (GLOBE NEWSWIRE) — Photronics, Inc. (NASDAQ: PLAB) faces a securities class action lawsuit after its investors saw the price of their shares plunge $19.49 (-36%) on May 28, 2026. The move lower was triggered by the company’s Q2 2026 results that brought into question the propriety of its earlier statements about its operations and prospects regarding its high-end integrated circuit (“IC”) photomask product line.

The lawsuit seeks to represent investors who purchased or otherwise acquired Photronics securities between December 10, 2025 and May 27, 2026.

National shareholders’ rights firm Hagens Berman is continuing its investigation into the legal claims that Photronics and its management misled investors and violated the federal securities laws. The firm encourages Photronics investors who suffered substantial losses to submit your losses now.

Class Period: Dec. 10, 2025 – May 27, 2026
Lead Plaintiff Deadline: Sept. 4, 2026
Visit:www.hbsslaw.com/investor-fraud/plab
Contact the Firm Now: [email protected]
                                          844-916-0895

Photronics, Inc. (PLAB) Securities Class Action:

Photronics is a leading manufacturer of photomasks, high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. IC sales comprise the bulk of Photronics’ total revenues.

During the Class Period, Photronics and its management touted “record in high-end IC […] thanks to a strong technology portfolio and exceptional execution.” They also emphasized that the company’s “[h]igh-end IC strength reflects strong order patterns globally, including in the U.S., […] where reshoring efforts continue to create a favorable demand environment.”

The company and its management continued to emphasize the “strong demand” for its high-end IC business throughout the Class Period and assured investors that “high-end strength will continue, as order demand remains healthy, to partially mitigate the upcoming seasonal impact following the Chinese New Year.”

The complaint alleges that Photronics and its management created the false impression that they had reliable information about revenue projections and growth while minimizing risks presented by post-holiday seasonality and macroeconomic fluctuations. The complaint further alleges that Photronics did not disclose to investors that its high-end chip design release pipeline was experiencing severe and ongoing bottlenecks due to elevated foundry use rates and equipment cost pressures.

On May 28, 2026 investors learned the truth. That day, Photronics’ operational reality became apparent when the company reported dismal financial results for its Q2 2026. Among the areas of concern were sequential declines in revenues (-6.7%), IC revenues (-11%), operating margins (-17.6%), GAAP net income (-26.8%), and non-GAAP net income (-30%).

In contrast to Class Period assurances, Photronics management in large part pinned the blame for the company’s consolidated and IC revenue declines on seasonality — “the seasonal recovery following the Chinese New Year has not occurred[.]” The company also revealed that bottlenecks had been created by high fab usage rates and a surge in memory prices.

In response, the market sent the price of Photronics shares down 36%, wiping out over $1.1 billion of the company’s market capitalization in a single day.

“Our investigation is focused on when Photronics and its management first knew that the company’s outlook and demand for its IC was deteriorating such that sequential and year-over-year revenues were declining,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Photronics and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to other frequently asked questions about the Photronics case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Photronics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

# # #

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: 

Reed Kathrein, 844-916-0895

Houston, TX, July 17, 2026 (GLOBE NEWSWIRE) — CO2 Energy Transition Corp. (Nasdaq: NOEM) today announced the signing of a non-binding Letter of Intent with a Texas-based operating oil and gas company with a track record of unconventional natural resource development in the United States. The target plans to recover lithium and strontium from subsurface brines produced from its own leased wells to support domestic critical mineral production and energy independence.

This initiative leverages the target company’s existing natural gas assets and oilfield infrastructure to create a three-prong revenue model — combining natural gas production with lithium and strontium recovery. This approach is designed to deliver increased revenue per barrel and provide downside protection against lithium price volatility.

“The energy transition creates a powerful opportunity to repurpose oilfield infrastructure for critical mineral recovery,” said Chuck Fox, Chairman of CO2 Energy Transition Corp. “This partnership aligns with our mission to build sustainable energy solutions and strengthen America’s supply chain security, particularly in defense applications.”

The target company plans to utilize proven extraction technologies in its processing plants in the near term while advancing longer-term process improvements. A core element of the long-term vision is producing low-cost strontium ferrite magnet materials domestically — enabling a “wellbore to weapons” advantage over traditional “mine to magnets” supply chains. This is particularly relevant for high-volume, low-cost applications such as one-way drones, which are increasingly treated as expendable munitions in modern defense strategies.

Strontium ferrite magnets represent a strategic pathway around rare earth dependency — fit-for-mission performance from domestic brine at a fraction of the cost. Lithium remains on the USGS critical minerals list, while substantial U.S. government investments — including DPA Title III awards and stockpile funding — underscore the strategic importance of domestic strontium production.

The parties intend to negotiate and enter into definitive agreements for the proposed business combination in good faith as soon as practicable, but in no event later than September 16, 2026, unless mutually extended. The transaction remains subject to the execution of definitive agreements, completion of due diligence, receipt of all necessary approvals, and other customary closing conditions.

Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that could cause such differences include, but are not limited to, the ability to negotiate and execute definitive agreements, results of due diligence, regulatory approvals, market conditions, and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update these forward-looking statements.

About CO2 Energy Transition Corp. CO2 Energy Transition Corp. (Nasdaq: NOEM) is a blank check company, commonly referred to as a special purpose acquisition company or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. While the Company may pursue a business combination target in any industry or geographic region, it is focused on opportunities in the energy transition sector, including critical minerals, sustainable power generation, and related infrastructure.

Contact Information:

CO2 Energy Transition Corp.
Charles Fox
Chairman
[email protected]
281-402-1888